Also categorized in BoardNews:
Getting Gen-Y on Boards (of Directors)
x hide permanently

Bristol-Myers Pushes Celgene Deal, Starboard Hits Back, in $74B Takeover Spat

Stock Market Today

Bristol-Myers Squibb ( BMY ) traded blows with activist investor Starboard Value LP Tuesday as the pair issued competing presentations linked to the pharmaceutical group's planned $74 billion takeover of cancer drug specialist Celgene Corp. ( CELG )...

Mentions: Management ISS Takeover